SOLIGENIX, INC. Increase (Decrease) in Income Taxes Receivable
SOLIGENIX, INC. (SNGX) reported Increase (Decrease) in Income Taxes Receivable of $836.89 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2021-05-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2021-05-18
- SOLIGENIX, INC. increase (decrease) in income taxes receivable for the quarter ending 2020-03-31 was $836.89K, a 37.04% increase year-over-year.
- SOLIGENIX, INC. increase (decrease) in income taxes receivable for the quarter ending 2019-03-31 was $610.68K.
- SOLIGENIX, INC. increase (decrease) in income taxes receivable for the quarter ending 2018-12-31 was $0.00.
- SOLIGENIX, INC. increase (decrease) in income taxes receivable for the quarter ending 2018-09-30 was $0.00.
- SOLIGENIX, INC. increase (decrease) in income taxes receivable for fiscal 2018 was -$416.81K, a 200.00% decline from fiscal 2017.
- SOLIGENIX, INC. increase (decrease) in income taxes receivable for fiscal 2017 was $416.81K.
- SOLIGENIX, INC. increase (decrease) in income taxes receivable for fiscal 2014 was -$750.36K, a 200.00% decline from fiscal 2013.
- SOLIGENIX, INC. increase (decrease) in income taxes receivable for fiscal 2013 was $750.36K.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|---|---|---|
| 2020-03-31 | $836.89K 10-Q · filed 2021-05-18 | |||
| 2019-03-31 | $610.68K 10-Q · filed 2019-05-14 | $610.68K derived: sum of 2 quarters · filed 2019-05-14 | $610.68K derived: sum of 3 quarters · filed 2019-11-12 | $610.68K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 derived: sum of 3 quarters · filed 2019-11-12 | -$416.81K 10-K · filed 2019-03-26 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | -$416.81K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$416.81K 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | -$416.81K 10-Q · filed 2019-05-14 | |||
| 2017-12-31 | $416.81K 10-K · filed 2019-03-26 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | $0.00 derived: sum of 2 quarters · filed 2016-03-24 | $0.00 derived: sum of 3 quarters · filed 2016-03-24 | -$750.36K 10-K · filed 2016-03-24 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-11-12 | -$750.36K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$750.36K 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | -$750.36K 10-Q · filed 2015-05-14 | |||
| 2013-12-31 | $750.36K 10-K · filed 2015-03-25 | |||
| 2012-12-31 | -$574.16K 10-K · filed 2014-03-26 | |||
| 2012-03-31 | -$574.16K 10-Q · filed 2013-05-03 | |||
| 2011-12-31 | $322.29K 10-K · filed 2013-02-26 | |||
| 2011-03-31 | -$247.54K 10-Q · filed 2012-05-14 | |||
| 2010-12-31 | $251.86K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |